by Ricky anand
Sanskritech is the developer of Swayam, a transportable diagnostic and tele-remedy point-of-care (POC) system, which may be used to create a small lab everywhere much like the scale of an ATM kiosk. Mylab Discovery Solutions, a biotech company, on Monday introduced acquisition of a majority stake in health-tech start-up Sanskritech for an undisclosed sum.
Sanskritech is the developer of Swayam, a transportable diagnostic and tele-remedy point-of-care (POC) system, which may be used to create a small lab everywhere much like the scale of an ATM kiosk. “During the second one wave of the pandemic, we noticed overburdening of our checking out structures. It have become obtrusive that decentralised checking out might notably enhance get entry to and turnaround times. POC labs could be a game-changer withinside the diagnostics space,” Hasmukh Rawal, handling director, Mylab, stated.
Mylab is centered on molecular, serological and immunology checking out solutions, diagnostics equipment, drug discovery and biomedical research. Pritam Kumawat, founding father of Sanskritech, stated this become a boot-strapped challenge and that they sought buyers to amplify attain and scale up. “All formof technology existed withinside the usa however get entry to to early analysis become an trouble so become price,” Kumawat stated.
Through an IoT primarily based totally POC system, Swayam had leveraged generation to create an smooth get entry to to primary healthcare at an low cost price and with Mylab they had been searching at making checking out to be had to be had throughout the usa, Kumawat stated. As a part of the deal, Mylab will gather a majority stake in Sanskritech in an all-coins deal. The Sansktitech crew will hold to perform as a separate entity beneathneath the aegis of Mylab. Mylab plans to set up greater than 1,000 POC structures withinside the subsequent years and begin deployment of those structures with lab companions from November 2021